Royal Plus PCL (BKK:PLUS)
Thailand · Delayed Price · Currency is THB 1.190
+0.030 (2.59%)
Sep 4, 2026, 4:35 PM ICT
Royal Plus PCL Revenue
Royal Plus PCL had revenue of 267.00M THB in the quarter ending March 31, 2026, a decrease of -7.08%. This brings the company's revenue in the last twelve months to 1.30B, down -7.38% year-over-year. In the year 2025, Royal Plus PCL had annual revenue of 1.32B, down -7.74%.
Revenue (ttm)
1.30B
Revenue Growth
-7.38%
P/S Ratio
0.60
Revenue / Employee
n/a
Employees
n/a
Market Cap
777.20M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.32B | -110.78M | -7.74% |
| Dec 31, 2024 | 1.43B | 3.93M | 0.28% |
| Dec 31, 2023 | 1.43B | -18.12M | -1.25% |
| Dec 31, 2022 | 1.44B | 435.50M | 43.14% |
| Dec 31, 2021 | 1.01B | -97.00M | -8.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CP ALL PCL | 1.05T |
| Charoen Pokphand Foods PCL | 566.02B |
| CP Axtra PCL | 526.70B |
| Thai President Foods PCL | 26.91B |
| Bioscience Animal Health PCL | 2.23B |
| Asian Palm Oil PCL | 2.10B |
| Premier Quality Starch PCL | 2.00B |
| Madame Bioscience PCL | 1.58B |